OPKO Health, Inc. (OPK) vs Replimune Group, Inc. (REPL)

A side-by-side comparison of OPKO Health, Inc. and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OPK vs REPL

growth of $100 · dividends reinvested · last 8y
OPK -75.0% (-15.9%/yr)REPL -13.3% (-1.8%/yr)REPL compounded faster over this window
0100200300Start $1002020202220242026$25$87
OPK REPL

OPK vs REPL: by the numbers

  • •REPL is the larger company ($1.11B vs $1.10B market cap).
  • •Both run net losses; REPL's is the smaller (0.00% vs -12.40% net margin).

Metrics side by side

Valuation

MetricOPKREPL
P/S ratio1.88N/A
P/B ratio0.9310.52

Profitability

MetricOPKREPL
Gross margin21.10%0.00%
Operating margin-36.08%0.00%
Net margin-12.40%0.00%
ROE-6.16%-281.14%
ROIC-8.86%-139.11%

Growth (annualized)

MetricOPKREPL
Revenue CAGR (5Y)-21.00%N/A
Total return CAGR (5Y)-15.39%-15.17%

Frequently asked

How have OPK and REPL total returns compared?
Over the past 5 years, OPK delivered -15.39% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.